RESUMO
Curcumin, a phenolic compound extracted from Curcuma longa, exerts multiple pharmacological effects, including an antimicrobial action. Mycobacterium abscessus, an environmental, nontuberculous, rapidly growing mycobacterium, is an emerging human pathogen causing serious lung infections and one of the most difficult to treat, due to its multidrug resistance and biofilm-forming ability. We wanted to evaluate the antimicrobial and antivirulence activity of curcumin and its ability to synergize with antibiotics against a clinical M. abscessus strain (29904), isolated from the bronchoaspirate of a 66-year-old woman admitted to hospital for suspected tuberculosis. Curcumin [minimum inhibitory concentrations (MIC) = 128 mg/L] was synergic (fractional inhibitory concentration index ≤0.5) with amikacin, clarithromycin, ciprofloxacin, and linezolid, to which strain 29904 showed resistance/intermediate susceptibility. Curcumin at 1/8 × MIC significantly reduced motility, whereas at 4 × MIC, it completely inhibited 4- and 8-day mature biofilms. Synergistic combinations of curcumin and amikacin induced a general reduction in microbial aggregates and substantial loss in cell viability. Disruption of 4- and 8-day biofilms was the main effect detected when curcumin was the predominant compound. The present findings support previous evidence that curcumin is a potential antibiotic resistance breaker. Curcumin, either alone or combined with antibiotics, could provide a novel strategy to combat antibiotic resistance and virulence of M. abscessus.
Assuntos
Amicacina/uso terapêutico , Curcumina/uso terapêutico , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Mycobacterium abscessus/patogenicidade , Amicacina/farmacologia , Curcumina/farmacologia , Humanos , Infecções por Mycobacterium não Tuberculosas/patologiaAssuntos
Antibacterianos/uso terapêutico , Hipertermia Induzida , Infecções por Mycobacterium não Tuberculosas/diagnóstico , Mycobacterium marinum/isolamento & purificação , Idoso , Animais , Biópsia , Terapia Combinada/métodos , Antebraço , Mãos , Humanos , Masculino , Pessoa de Meia-Idade , Infecções por Mycobacterium não Tuberculosas/microbiologia , Infecções por Mycobacterium não Tuberculosas/patologia , Infecções por Mycobacterium não Tuberculosas/terapia , Pele/microbiologia , Pele/patologia , Resultado do TratamentoRESUMO
Mycobacterium kansasii, most virulent of all atypical mycobacteria, causes pulmonary disease identical to the disease caused by Mycobacterium tuberculosis. Early identification of the species and prompt initiation of treatment for M. kansasii is necessary to prevent morbidity and mortality due to this disease. This case series highlights the similarity in the clinical presentation of both M. tuberculosis and M. kansasii and response to direct observation of short-course chemotherapy with rifampicin, in the management of pulmonary M. kansasii disease. Larger studies are required to evaluate the long-term effect of short-course chemotherapy, especially use of moxifloxacin, in the management of pulmonary M. kansasii disease.
Assuntos
Antibacterianos/uso terapêutico , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Infecções por Mycobacterium não Tuberculosas/microbiologia , Mycobacterium kansasii/isolamento & purificação , Pneumonia Bacteriana/tratamento farmacológico , Pneumonia Bacteriana/microbiologia , Adulto , Diagnóstico Diferencial , Fluoroquinolonas/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Moxifloxacina , Infecções por Mycobacterium não Tuberculosas/patologia , Pneumonia Bacteriana/patologia , Rifampina/uso terapêutico , Resultado do Tratamento , Tuberculose Pulmonar/microbiologia , Tuberculose Pulmonar/patologia , Adulto JovemRESUMO
No disponible
Assuntos
Humanos , Masculino , Feminino , Doença Granulomatosa Crônica/diagnóstico , Doença Granulomatosa Crônica/genética , Doença Granulomatosa Crônica/imunologia , Mycobacterium tuberculosis/genética , Mycobacterium tuberculosis/imunologia , Mycobacterium tuberculosis/patogenicidade , Mutação/imunologia , Mutação/fisiologia , NADPH Oxidases/imunologia , NADPH Oxidases/uso terapêutico , Burkholderia cepacia/patogenicidade , Staphylococcus aureus/patogenicidade , Salmonella/patogenicidade , Serratia marcescens/patogenicidade , Nocardia/patogenicidade , Aspergillus/patogenicidade , Infecções por Mycobacterium não Tuberculosas/imunologia , Infecções por Mycobacterium não Tuberculosas/patologia , Rifampina/uso terapêutico , Isoniazida/uso terapêutico , Clotrimazol/uso terapêutico , Tuberculose/imunologia , Tuberculose/patologiaRESUMO
Mycobacterium abscessus is a rapidly growing mycobacterium that has been affecting people undergoing invasive procedures, such as videosurgery and mesotherapy. This bacterium has global distribution, being found in numerous niches. The frequency of published reports of infection by rapidly growing mycobacteria associated with tattooing procedures has increased in recent years. However, in Brazil there were no case reports of M. abscessus after tattooing in the literature until now. In this paper, we describe the case of a patient with a nine-month history of lesion on a tattoo site. The diagnosis of infection with Mycobacterium abscessus was established by correlation between dermatological and histopathological aspects, culture and molecular biology techniques. The patient had significant improvement of symptoms with the use of clarithromycin monotherapy.
Assuntos
Infecções por Mycobacterium não Tuberculosas/etiologia , Dermatopatias Bacterianas/etiologia , Tatuagem/efeitos adversos , Adulto , Brasil , Feminino , Humanos , Infecções por Mycobacterium não Tuberculosas/patologia , Micobactérias não Tuberculosas , Dermatopatias Bacterianas/patologiaRESUMO
AbstractMycobacterium abscessus is a rapidly growing mycobacterium that has been affecting people undergoing invasive procedures, such as videosurgery and mesotherapy. This bacterium has global distribution, being found in numerous niches. The frequency of published reports of infection by rapidly growing mycobacteria associated with tattooing procedures has increased in recent years. However, in Brazil there were no case reports of M. abscessus after tattooing in the literature until now. In this paper, we describe the case of a patient with a nine-month history of lesion on a tattoo site. The diagnosis of infection with Mycobacterium abscessus was established by correlation between dermatological and histopathological aspects, culture and molecular biology techniques. The patient had significant improvement of symptoms with the use of clarithromycin monotherapy.
Assuntos
Adulto , Feminino , Humanos , Infecções por Mycobacterium não Tuberculosas/etiologia , Dermatopatias Bacterianas/etiologia , Tatuagem/efeitos adversos , Brasil , Infecções por Mycobacterium não Tuberculosas/patologia , Micobactérias não Tuberculosas , Dermatopatias Bacterianas/patologiaRESUMO
Pulmonary infections caused by nontuberculous mycobacteria (NTM) are an increasing problem in individuals with chronic lung conditions and current therapies are lacking. We investigated the activity of liposomal amikacin for inhalation (LAI) against NTM in vitro as well as in a murine model of respiratory infection. Macrophage monolayers were infected with three strains of Mycobacterium avium, two strains of Mycobacterium abscessus, and exposed to LAI or free amikacin for 4 days before enumerating bacterial survival. Respiratory infection was established in mice by intranasal inoculation with M. avium and allowing three weeks for the infection to progress. Three different regimens of inhaled LAI were compared to inhaled saline and parenterally administered free amikacin over a 28 day period. Bacteria recovered from the mice were analyzed for acquired resistance to amikacin. In vitro, liposomal amikacin for inhalation was more effective than free amikacin in eliminating both intracellular M. avium and M. abscessus. In vivo, inhaled LAI demonstrated similar effectiveness to a â¼25% higher total dose of parenterally administered amikacin at reducing M. avium in the lungs when compared to inhaled saline. Additionally, there was no acquired resistance to amikacin observed after the treatment regimen. The data suggest that LAI has the potential to be an effective therapy against NTM respiratory infections in humans.
Assuntos
Amicacina/administração & dosagem , Amicacina/uso terapêutico , Antituberculosos/uso terapêutico , Sistemas de Liberação de Medicamentos , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Micobactérias não Tuberculosas/efeitos dos fármacos , Infecções Respiratórias/tratamento farmacológico , Administração por Inalação , Aerossóis , Amicacina/farmacologia , Animais , Antituberculosos/administração & dosagem , Antituberculosos/farmacologia , Linhagem Celular , Contagem de Colônia Microbiana , Modelos Animais de Doenças , Farmacorresistência Bacteriana/efeitos dos fármacos , Feminino , Humanos , Espaço Intracelular/microbiologia , Lipossomos , Pulmão/efeitos dos fármacos , Pulmão/microbiologia , Pulmão/patologia , Camundongos Endogâmicos C57BL , Testes de Sensibilidade Microbiana , Infecções por Mycobacterium não Tuberculosas/microbiologia , Infecções por Mycobacterium não Tuberculosas/patologia , Micobactérias não Tuberculosas/isolamento & purificação , Infecções Respiratórias/microbiologia , Infecções Respiratórias/patologiaAssuntos
Pontos de Acupuntura , Terapia por Acupuntura/efeitos adversos , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Infecções por Mycobacterium não Tuberculosas/etiologia , Mycobacterium fortuitum/isolamento & purificação , Terapia por Acupuntura/métodos , Adulto , Biópsia por Agulha , Bochecha , Ciprofloxacina/administração & dosagem , Claritromicina/administração & dosagem , Doxiciclina/administração & dosagem , Quimioterapia Combinada , Feminino , Seguimentos , Humanos , Imuno-Histoquímica , Infecções por Mycobacterium não Tuberculosas/patologia , Doenças Raras , Índice de Gravidade de Doença , Resultado do TratamentoRESUMO
We report 3 cases of Mycobacterium chelonae infections after bee venom acupuncture. All were treated with antibiotics and surgery. Mycobacterium chelonae infections should be included in the differential diagnosis of chronic skin and soft tissue infections following bee venom acupuncture.
Assuntos
Acupuntura/métodos , Venenos de Abelha/efeitos adversos , Infecções por Mycobacterium não Tuberculosas/diagnóstico , Infecções por Mycobacterium não Tuberculosas/microbiologia , Mycobacterium chelonae/isolamento & purificação , Dermatopatias Bacterianas/diagnóstico , Dermatopatias Bacterianas/microbiologia , Adulto , Antibacterianos/uso terapêutico , Venenos de Abelha/administração & dosagem , Desbridamento , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infecções por Mycobacterium não Tuberculosas/patologia , Infecções por Mycobacterium não Tuberculosas/terapia , Pele/diagnóstico por imagem , Pele/patologia , Dermatopatias Bacterianas/patologia , Dermatopatias Bacterianas/terapia , Resultado do Tratamento , UltrassonografiaAssuntos
Hipertermia Induzida , Infecções por Mycobacterium não Tuberculosas/terapia , Mycobacterium chelonae/crescimento & desenvolvimento , Dermatopatias Bacterianas/terapia , Idoso , Antibacterianos/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Colite Ulcerativa/tratamento farmacológico , Humanos , Masculino , Minociclina/uso terapêutico , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Infecções por Mycobacterium não Tuberculosas/patologia , Mycobacterium chelonae/efeitos dos fármacos , Mycobacterium chelonae/isolamento & purificação , Infiltração de Neutrófilos , Ofloxacino/uso terapêutico , Prednisolona/uso terapêutico , Dermatopatias Bacterianas/tratamento farmacológico , Dermatopatias Bacterianas/patologia , Resultado do TratamentoRESUMO
One-third of the world population is infected with Mycobacterium tuberculosis and multi-drug resistant strains are rapidly evolving. The noticeable absence of a whole organism high-throughput screening system for studying the progression of tuberculosis is fast becoming the bottleneck in tuberculosis research. We successfully developed such a system using the zebrafish Mycobacterium marinum infection model, which is a well-characterized model for tuberculosis progression with biomedical significance, mimicking hallmarks of human tuberculosis pathology. Importantly, we demonstrate the suitability of our system to directly study M. tuberculosis, showing for the first time that the human pathogen can propagate in this vertebrate model, resulting in similar early disease symptoms to those observed upon M. marinum infection. Our system is capable of screening for disease progression via robotic yolk injection of early embryos and visual flow screening of late-stage larvae. We also show that this system can reliably recapitulate the standard caudal vein injection method with a throughput level of 2,000 embryos per hour. We additionally demonstrate the possibility of studying signal transduction leading to disease progression using reverse genetics at high-throughput levels. Importantly, we use reference compounds to validate our system in the testing of molecules that prevent tuberculosis progression, making it highly suited for investigating novel anti-tuberculosis compounds in vivo.
Assuntos
Biomarcadores/análise , Ensaios de Triagem em Larga Escala/métodos , Tuberculose/diagnóstico , Animais , Antituberculosos/isolamento & purificação , Antituberculosos/uso terapêutico , Modelos Animais de Doenças , Progressão da Doença , Avaliação Pré-Clínica de Medicamentos/métodos , Embrião não Mamífero , Humanos , Infecções por Mycobacterium não Tuberculosas/diagnóstico , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Infecções por Mycobacterium não Tuberculosas/patologia , Mycobacterium marinum/fisiologia , Prognóstico , Tuberculose/tratamento farmacológico , Tuberculose/patologia , Peixe-Zebra/embriologia , Peixe-Zebra/crescimento & desenvolvimento , Peixe-Zebra/fisiologiaRESUMO
Biotin, which functions as an essential cofactor for certain carboxylases and decarboxylases, is synthesized by a multistep pathway in microorganisms and plants. Biotin biosynthesis has not been studied in detail in mycobacteria. In this study, we isolated a mutant of Mycobacterium marinum in which MMAR_2770, a previously uncharacterized gene encoding a predicted short-chain dehydrogenase/reductase, was inactivated. We found that this mutant is a biotin auxotroph that cannot grow in a minimal medium (Sauton) unless biotin is supplemented. Complementation of the mutant with an intact MMAR_2770 or its homolog Rv1882c of Mycobacterium tuberculosis restored the growth of the mutant, suggesting that MMAR_2770 is involved in biotin biosynthesis. We further showed that the mutant was unable to grow in cultured macrophages and was attenuated in zebrafish. Taken together, our results demonstrate that biotin biosynthesis is essential for the growth of mycobacteria in vitro and in vivo and have provided validation for targeting biotin biosynthetic enzymes for antimycobacterial drug development. The potential role of MMAR_2770 in mycobacterial biotin biosynthesis is discussed.
Assuntos
Proteínas de Bactérias , Biotina , Macrófagos/microbiologia , Infecções por Mycobacterium não Tuberculosas/enzimologia , Infecções por Mycobacterium não Tuberculosas/microbiologia , Mycobacterium marinum/enzimologia , Peixe-Zebra/microbiologia , Animais , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Biotina/biossíntese , Linhagem Celular , Camundongos , Mutação , Infecções por Mycobacterium não Tuberculosas/patologia , Mycobacterium marinum/genética , Mycobacterium marinum/crescimento & desenvolvimentoRESUMO
There are no pathognomonic findings for cutaneous infection caused by Mycobacterium chelonae. The type and duration of therapy varies considerably among reports and no single antibiotic is considered the treatment of choice. A 61-year-old patient, suffering from rheumatoid arthritis (treated with metotrexate and salazopyrine), presented with violaceous nodules of the right leg that had been evolving for 6 months. She was underwent several skin biopsies. Tissue culture of the last showed an atypical mycobacteria, identified as M. chelonae. Despite improvement after a two-week course of treatment with clarithromycin, a switch to ciprofloxacin was made because of gastrointestinal intolerance. After 3 months, only slight improvement of the lesions was achieved and clarithromycin was reintroduced; significant clinical improvement occurred by the third month. Clarithromycin was continued a further two months until the patient quit on her own and. no recurrence was observed. Infections caused by M. chelonae frequently occur in the setting of immunological impairment. Contaminated water is the natural reservoir, but we were unable to establish the source of contamination. As was previously described, there was a significant delay between clinical presentation and diagnosis. Thus, a high index of suspicion and multiple biopsies with culture are of paramount importance to confirming the diagnosis.
Assuntos
Antibacterianos/uso terapêutico , Artrite Reumatoide/tratamento farmacológico , Ciprofloxacina/uso terapêutico , Claritromicina/uso terapêutico , Imunossupressores/efeitos adversos , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Mycobacterium chelonae , Tuberculose Cutânea/tratamento farmacológico , Combinação de Medicamentos , Feminino , Glucosamina/efeitos adversos , Glucosamina/análogos & derivados , Glucosamina/uso terapêutico , Humanos , Imunossupressores/uso terapêutico , Perna (Membro) , Metotrexato/efeitos adversos , Metotrexato/uso terapêutico , Pessoa de Meia-Idade , Infecções por Mycobacterium não Tuberculosas/imunologia , Infecções por Mycobacterium não Tuberculosas/patologia , Sulfassalazina/efeitos adversos , Sulfassalazina/uso terapêutico , Tuberculose Cutânea/imunologia , Tuberculose Cutânea/patologiaRESUMO
BACKGROUND: Cutaneous infections caused by Mycobacterium fortuitum usually are a complication of trauma or postsurgical wounds. CASE REPORT: A 41-year-old woman presented with numerous dusky red nodules, abscesses and sinuses on the right buttock and on the lateral surfaces of both thighs. The lesions developed at the injection sites of mesotherapy treatment. M. fortuitum was cultured from a biopsy specimen and purulent fluid drained from lesions. The lesions had cleared completely with ciprofloxacin 500 mg b.d. for 3 weeks, and then 250 mg b.d. for another 3 weeks. CONCLUSIONS: This case demonstrates the importance of suspecting mycobacterial etiology in patients with nodules and abscesses in the areas of mesotherapy treatment.
Assuntos
Técnicas Cosméticas/efeitos adversos , Infecções por Mycobacterium não Tuberculosas/etiologia , Mycobacterium fortuitum , Fitoterapia/efeitos adversos , Dermatopatias Bacterianas/etiologia , Adulto , Aesculus , Anti-Infecciosos/uso terapêutico , Biópsia , Ciprofloxacina/uso terapêutico , Feminino , Humanos , Microinjeções/efeitos adversos , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Infecções por Mycobacterium não Tuberculosas/patologia , Dermatopatias Bacterianas/tratamento farmacológico , Dermatopatias Bacterianas/patologia , Gordura SubcutâneaRESUMO
BACKGROUND: Mesotherapy is an increasingly used technique which is currently causing several mycobacterial infections owing to contaminated substances being injected, and also to poor aseptic measures being held by nonprofessional practitioners. PATIENTS AND METHODS: We collected 15 cases of nontuberculous mycobacteria (NTM) infection after mesotherapy in a 6-month period. RESULTS: All patients were female with ages ranging from 19 to 52 years; the main substances injected were procaine and lecithin, and the time between mesotherapy and the appearance of the lesions varied between 1 and 12 weeks. Clinical lesions were mostly nodules and abscesses, which were localized in the abdomen and buttocks in the majority of cases. The main patient complaint was local pain but some presented with systemic symptoms such as fever and malaise. Biopsies reported granulomatous chronic inflammation in the majority of cases. Skin cultures were positive for NTM and Mycobacterium chelonae. DISCUSSION AND CONCLUSIONS: Mesotherapy not performed with quality controlled substances can be a predisposing factor for NTM infection.
Assuntos
Contaminação de Medicamentos , Injeções/efeitos adversos , Infecções por Mycobacterium não Tuberculosas/etiologia , Micobactérias não Tuberculosas/isolamento & purificação , Dermatopatias Bacterianas/etiologia , Adulto , Colômbia , Técnicas Cosméticas/efeitos adversos , Feminino , Humanos , Pessoa de Meia-Idade , Infecções por Mycobacterium não Tuberculosas/patologia , Mycobacterium chelonae/isolamento & purificação , Dermatopatias Bacterianas/patologiaAssuntos
Infecções por Mycobacterium não Tuberculosas/diagnóstico , Dermatopatias Bacterianas/diagnóstico , Cicatriz/patologia , Diagnóstico Diferencial , Feminino , Dedos/patologia , Humanos , Pessoa de Meia-Idade , Infecções por Mycobacterium não Tuberculosas/patologia , Infecções por Mycobacterium não Tuberculosas/terapia , Mycobacterium marinum/isolamento & purificação , Fototerapia , Dermatopatias Bacterianas/patologia , Dermatopatias Bacterianas/terapiaRESUMO
BACKGROUND: Despite the increasing popularity of acupuncture, the importance of infection control is not adequately emphasized in Oriental medicine. In December 2001, an Oriental medical doctor in Seoul, South Korea, encountered several patients with persistent, culture-negative skin lesions on the trunk and extremities at the sites of prior acupuncture treatment. We identified and investigated an outbreak of Mycobacterium abscessus cutaneous infection among the patients who attended this Oriental medicine clinic. METHODS: Patients were defined as clinic patients with persistent cutaneous infections at the acupuncture sites. Medical records for the previous 7 months were reviewed. Clinical specimens were obtained from the patients and an environmental investigation was performed. M. abscessus isolates, cultured from patients, were compared by pulsed-field gel electrophoresis (PFGE). RESULTS: Forty patients who attended the Oriental medicine clinic and experienced persistent cutaneous wound infections were identified. Cultures from five of these patients proved positive, and all other diagnoses were based on clinical and histopathologic examinations. All environmental objects tested were negative for M. abscessus, however, most were contaminated by various nosocomial pathogens. Molecular analysis using PFGE found all wound isolates to be identical. CONCLUSION: We have identified a large outbreak of rapidly growing mycobacterial infection among patients who received acupuncture at a single Oriental medicine clinic. Physicians should suspect mycobacterial infections in patients with persistent cutaneous infections following acupuncture, and infection control education including hygienic practice, should be emphasized for Oriental medical doctors practicing acupuncture.
Assuntos
Terapia por Acupuntura/efeitos adversos , Infecções por Mycobacterium não Tuberculosas/epidemiologia , Infecções por Mycobacterium não Tuberculosas/transmissão , Mycobacterium , Dermatopatias Bacterianas/epidemiologia , Dermatopatias Bacterianas/transmissão , Terapia por Acupuntura/normas , Adulto , Antibacterianos/uso terapêutico , Surtos de Doenças , Feminino , Humanos , Coreia (Geográfico)/epidemiologia , Masculino , Pessoa de Meia-Idade , Mycobacterium/classificação , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Infecções por Mycobacterium não Tuberculosas/patologia , Pele/patologia , Dermatopatias Bacterianas/tratamento farmacológico , Dermatopatias Bacterianas/microbiologia , Fatores de TempoRESUMO
BACKGROUND: Mycobacterial infections transmitted by acupuncture are an emerging problem. There have been two reports of mycobacterial infections complicating acupuncture in the English literature. AIM: To describe the clinical manifestations and treatment of patients who acquired localized Mycobacterium abscessus infection in the process of acupuncture. METHODS: Clinical manifestations and responses to different methods of treatment were reviewed in 40 patients who developed various skin lesions after acupuncture at a Korean oriental medicine clinic. Results The morphology of the lesions which developed at the acupuncture sites varied. Although the lesions disappeared with the combined administration of clarithromycin and amikacin for 3 months in most cases, five out of 25 patients (20%) showed residual lesions at the end of treatment, and had to be treated with a higher dosage of clarithromycin or alternative antibiotics based on sensitivity tests. CONCLUSIONS: We recommend at least 3 months of treatment with clarithromycin for treating skin infections caused by M. abscessus, with supplementary antibiotics selected based on patients' drug sensitivity tests.
Assuntos
Terapia por Acupuntura/efeitos adversos , Infecções por Mycobacterium não Tuberculosas/etiologia , Dermatopatias Bacterianas/etiologia , Adulto , Amicacina/uso terapêutico , Antibacterianos/uso terapêutico , Claritromicina/uso terapêutico , Feminino , Humanos , Doença Iatrogênica , Masculino , Pessoa de Meia-Idade , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Infecções por Mycobacterium não Tuberculosas/patologia , Pele/efeitos dos fármacos , Pele/patologia , Dermatopatias Bacterianas/tratamento farmacológico , Dermatopatias Bacterianas/patologia , Fatores de Tempo , Resultado do TratamentoRESUMO
Nine dogs with panniculitis due to rapidly growing mycobacteria (RGM) were examined over 17 years. Dogs were two to 15 years; five were male, four were female. All were obese or in good condition. Antecedent injury, typically a dog bite or vehicular trauma, could be identified in some patients, while one bitch had hyperadrenocorticism. Infections involved different locations, although the cervicothoracic region, dorsum or flank were most often affected. Patients were systemically well, apart from one dog with pyrexia and two with pain or lameness. Cytology demonstrated pyogranulomatous inflammation, but in only one case was it possible to see acid-fast bacilli (AFB) in smears. Histology demonstrated chronic active pyogranulomatous panniculitis and dermatitis; AFB could be detected in only four specimens. Culture of aspirates or resected tissues demonstrated RGM in all cases, comprising six Mycobacterium smegmatis group and three Mycobacterium fortuitum group isolates. Resection of infected tissues, perioperative injectable antimicrobials and long courses of oral antimicrobials chosen according to susceptibility data generally effected a cure, although some cases recurred.